[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prebiotic-fiber\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prebiotic-fiber":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":14,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100614661",false,"NCT07282496","Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial","Inclusion Criteria:\n\n* Subjects aged 18-65 years.\n* Healthy subjects (BMI between 18.5-24.9 kg\u002Fm² for women and men).\n* Subjects must be able to maintain a stable diet (based on the Ministry of Health and Welfare's daily dietary guidelines, with a tolerance of ± 10-15%) and physical activity (based on the World Health Organization's recommendations of 150-300 minutes of moderate-intensity exercise per week, or equivalent physical activity, with a tolerance of ± 20%) during the trial period.\n* Subjects must understand the trial procedures and potential risks and benefits described in the consent form and be able to sign the consent form.\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women.\n* Subjects with endocrine abnormalities, major organ disease, or mental illness (as determined by a physician).\n* Subjects found to be intolerant to the test sample during the trial.\n* Subjects who develop a disease or take medications or health supplements that could affect the results of the trial during the trial period. (e.g., hypoglycemic (lipid)-lowering medications, probiotics, high-dose dietary fiber supplements, fish oil, or supplements high in polyunsaturated fatty acids).\n* Chronic gastrointestinal diseases (e.g., diverticular disease, irritable bowel syndrome, or other intestinal diseases that may cause constipation).\n* Use of antibiotics within the past three months.",true,"ALL","18 Years","65 Years",{"count":19,"type":20},115,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to investigate the effects of RT-90 resistant cassava starch on glycemic control using a human dietary trial and to evaluate its potential as a prebiotic fiber supplement. This study will assess the efficacy of RT-90 resistant cassava starch in improving glycemic control, body composition, and gut microbiome in healthy individuals.",[26,27,28,29],"Resistant Starch","Tapioca Starch","Prebiotic Fiber","Blood Sugar","NOT_YET_RECRUITING","2025-12-01",{"date":33,"type":34},"2025-12-15","ACTUAL",{"date":36,"type":20},"2025-12-20",{"date":38,"type":20},"2026-10-31",{"name":40,"class":41},"Chung Shan Medical University","OTHER",""]